Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common Anti-Inflammatory replace opioids after hip surgery?

NCT ID NCT07037888

Symptom relief Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests whether ketorolac, a non-opioid anti-inflammatory drug, can control pain after hip arthroscopy as well as or better than standard opioid medications. About 100 adults with femoroacetabular impingement undergoing hip arthroscopy will be randomly assigned to receive either ketorolac plus standard care or standard care alone. Researchers will measure pain levels and opioid use over the first few days after surgery, with follow-up up to 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ketorolac
What this could lead to
If successful, this could offer a safer, non-opioid option for managing pain after hip arthroscopy, reducing addiction risk and side effects.
What could go wrong
This is a small, single-center Phase 4 trial, so results may not apply broadly. Ketorolac may not control pain as effectively as opioids for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing hip arthroscopy over the age of 18 with Dr. T. Sean Lynch * Diagnosis of femoroacetabular impingement (FAI) Exclusion Criteria: * Patients with inability to consent and/or do not speak English * Patients with conditions contraindicated with NSAIDs (medication allergy, peptic ulcer disease, bleeding diathesis, and renal disease) * Patients with history of drug and alcohol use disorder * Patients with chronic analgesia (filled two opioid prescriptions within 6 months of the surgery) * Patients with psychotropic medication usage * Patients who take pentoxifylline, probonecid, aspirin, and/or NSAIDs who cannot stop taking it for the study * Patients who are not discharged same day after surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Femoracetabular impingement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Femoracetabular Impingement

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Femoracetabular impingement Hip arthroscopy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Henry Ford Health

    RECRUITING

    Detroit, Michigan, 48202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.